Mantle cell lymphoma (MCL)
- Treatment depends on age, fitness + disease tempo
- Selected indolent cases can be observed initially
- Immunochemotherapy or targeted combinations are used first-line
- BTK inhibitors are central in relapsed disease
- Cellular therapy is an option for selected refractory disease
- Maintenance rituximab is used in some strategies
Use at a glance
- Treatment depends on age, fitness + disease tempo
Monitoring / follow-up
- Selected indolent cases can be observed initially
- Maintenance rituximab is used in some strategies
Treatment options
- Immunochemotherapy or targeted combinations are used first-line
Escalation / refractory disease
- BTK inhibitors are central in relapsed disease
- Cellular therapy is an option for selected refractory disease
Self-check
- What is an option for selected refractory mantle cell lymphoma?
Cellular therapy. - Which MCL cases can initially be observed?
Selected indolent cases.
Drugs used for this (3)
All clinical uses · Open Mantle cell lymphoma (MCL) in the interactive console ↗